Evidence map›Paper›PMID 31391700›Full record

ReviewMedical archives (Sarajevo, Bosnia and Herzegovina)2019

Cystic Fibrosis Gene Mutation Frequency Among a Group of Suspected Children in King Hussein Medical Center.

Baheieh Al-Abadi, Mansour Al-Hiary, Rami Khasawneh, Asim Al-Momani, Ahmad Bani-Salameh, Sanaa Al-Saeidat, Alia Al-Khlaifat, Omaima Aboalsondos

Open access · greenAbstract readReview
In one paragraph

Review in Medical archives (Sarajevo, Bosnia and Herzegovina), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.4field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Heart rate variability, exercise capacity and levels of daily physical activity in children and adolescents with mild-to-moderate cystic fibrosis.Hong Kong physiotherapy journal : official publication of the Hong Kong Physiotherapy Association Limited = Wu li chih liao · 2022
    Article
  6. Article
  7. Molecular analysis ofThe Egyptian journal of medical human genetics · 2021
    Article
  8. Article
  9. Multidisciplinary approach to patients with manifestations and pulmonary complications of cystic fibrosis.Romanian journal of morphology and embryology = Revue roumaine de morphologie et embryologie
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Baheieh Al-AbadiImmunology Department, Prince Iman Center, Amman, Jordan.
Mansour Al-HiaryImmunology Department, Prince Iman Center, Amman, Jordan.
Rami KhasawnehHematology Department, Prince Iman Center, Amman, Jordan.
Asim Al-MomaniHematology Department, Prince Iman Center, Amman, Jordan.
Ahmad Bani-SalamehInternal Medicine, King Hussein Medical Center, Amman, Jordan.
Sanaa Al-SaeidatHematology Department, Prince Iman Center, Amman, Jordan.
Alia Al-KhlaifatPediatric Department, King Hussein Medical Center, Amman, Jordan.
Omaima AboalsondosImmunology Department, Prince Iman Center, Amman, Jordan.
King Hussein Medical Center · JO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionCystic fibrosis (CF) is a genetic multisystem disorder that affects mostly the lungs, but other organs such as liver, pancreas and intestine also affected. CF is inherited in an autosomal recessive manner and occurs in males and females equally. Cystic fibrosis Transmembrane Conductance Regulator (CFTR) mutations are classified into five classes. Class 1 (non-functional protein), class 2 (near-absence of mature CFTR protein at the apical cell membrane), class 3 (full-length CFTR protein incorporated into the cell membrane), class 4 (reduced conductance CFTR mutation), and class 5 (reduced amount of CFTR protein with normal function). Globally F508 mutation is the most common.

aimThe aim of this study was to determine the frequency of CFTR gene mutation in Jordanian populations attending a major hospital (KHMC). MATERIAL AND

methodsThis is a retrospective study was conducted on 777 sera samples for patients clinically suspected to have cystic fibrosis over a six year period 1/1/2013-1/10/2018. The patient's age range between 1year and 33 years, of which 59.2% (460) were male and 40.8% (317) female. Blood samples were analyzed at Princess Iman Centre for Research and Laboratory Sciences at King Hussein Medical Centre. The samples were tested for 34 mutations of CFTR gene using CF Strip Assay VIENNA LAB Diagnostics GmbH, Austria by polymerase chain reaction (PCR).

resultsA total of 777 patients samples were analyzed for cystic gene mutations. Twelve (12) mutations were identified. In 49 patients (6.3%) were heterozygous genotype mutant and 28 (3.6%) were homozygous. The most frequent mutation F508del was found in 32/77 (41.5%). 20 (25.9%) of them were heterozygous genotype mutant and 12 (15.6%) were homozygous genotype mutant. The second frequent mutation was N1303K with frequency rate 15.6% (12/77), 9 (11.7%) of them were heterozygous and 3 (3.9%) were homozygous. Regarding frequency of cystic fibrosis gene mutation depending on sex, 55.8% (43/77) of mutations were found in male, whereas 44.2% (34/77) in female.

conclusionOur findings suggest that cystic fibrosis in Jordan is not a rare disease, and found that the most frequent CFTR gene mutation was F508del, which is in keeping with results from other Mediterranean countries.

Indexed as

AdolescentAdultChildChild, PreschoolCystic FibrosisCystic Fibrosis Transmembrane Conductance RegulatorFemaleGenotypeHeterozygoteHomozygoteHumansInfantJordanMaleMutationRetrospective StudiesCFTR protein, humanCystic Fibrosis Transmembrane Conductance RegulatorCFTR geneCystic fibrosismutation genotype

Identifiers

PMID31391700
PMCPMC6643337
OpenAlexW2937733152

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.